Direct immunofluorescence in lupus erythematosus (LE)

R S Isfer1, J A Sanches Júnior, C Festa Neto

  • 1General Hospital Dermatology Clinic, University of São Paulo Medical School, Brasil.

Insights

Direct immunofluorescence (DIF) detected specific immunoglobulins in lupus erythematosus (LE) skin lesions. IgM and IgM + C3 were the most common findings, aligning with existing lupus research.

Area of Science:

  • Dermatology
  • Immunology
  • Pathology

Background:

  • Lupus erythematosus (LE) encompasses various autoimmune conditions affecting the skin.
  • Cutaneous lupus erythematosus (CLE) subtypes include discoid lupus erythematosus (DLE), subacute cutaneous lupus erythematosus (SALE), and systemic lupus erythematosus (SLE).
  • Direct immunofluorescence (DIF) is a diagnostic tool for identifying immune deposits in skin biopsies.

Purpose of the Study:

  • To evaluate the utility of DIF in diagnosing cutaneous lupus erythematosus.
  • To determine the prevalence of specific immunoglobulins and complement deposition in skin lesions of different LE subtypes.

Main Methods:

  • A cohort of 126 patients with LE was studied, categorized into DLE (84), SALE (13), and SLE (29).
  • Skin biopsies were obtained from lesional skin.
  • Direct immunofluorescence (DIF) was performed on all biopsies.

Main Results:

  • Positive DIF results were observed in 69% of DLE, 61.5% of SALE, and 72.4% of SLE cases.
  • Immunoglobulin M (IgM) was the most frequently detected immunoglobulin.
  • The combined finding of IgM and C3 was the next most common immune deposit.

Conclusions:

  • DIF is a valuable diagnostic method for cutaneous lupus erythematosus.
  • IgM and IgM + C3 deposits are characteristic findings in LE skin lesions.
  • The prevalence of positive DIF results is consistent across DLE, SALE, and SLE subtypes.